Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CRISPR Therapeutics AG | 255,501 | reported | 23 Mar 2026 | tx 300+4,616,836−2,580,757 |
| Centessa Pharmaceuticals plc | 40,000 | reported | 20 Jun 2025 | tx 4+184,000 |
| Black Diamond Therapeutics, Inc. | 30,550 | reported | 12 Jun 2025 | tx 6+122,521 |
| Repare Therapeutics Inc. | 27,200 | reported | 17 Jun 2024 | tx 4+124,400 |
| Oruka Therapeutics, Inc. | 17,500 | reported | 02 Jun 2025 | tx 1+17,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Mar 2026 | SALE | CRISPR Therapeutics AG | 10,020 | 46.78 USD | |
| 20 Mar 2026 | EXERCISE | CRISPR Therapeutics AG | 19,687 | — | |
| 20 Mar 2026 | EXERCISE | CRISPR Therapeutics AG | 19,687 | — | deriv |
| 20 Mar 2026 | GRANT_AWARD | CRISPR Therapeutics AG | 81,875 | 0.00 USD | deriv |
| 20 Mar 2026 | GRANT_AWARD | CRISPR Therapeutics AG | 114,249 | 0.00 USD | deriv |
| 14 Mar 2026 | EXERCISE | CRISPR Therapeutics AG | 20,625 | — | |
| 16 Mar 2026 | SALE | CRISPR Therapeutics AG | 10,349 | 48.26 USD | |
| 14 Mar 2026 | EXERCISE | CRISPR Therapeutics AG | 20,625 | — | deriv |
| 10 Mar 2026 | EXERCISE | CRISPR Therapeutics AG | 19,250 | — | |
| 11 Mar 2026 | SALE | CRISPR Therapeutics AG | 9,798 | 52.80 USD | |
| 10 Mar 2026 | EXERCISE | CRISPR Therapeutics AG | 19,250 | — | deriv |
| 18 Feb 2026 | EXERCISE | CRISPR Therapeutics AG | 13,250 | — | |
| 19 Feb 2026 | SALE | CRISPR Therapeutics AG | 6,967 | 52.58 USD | |
| 18 Feb 2026 | EXERCISE | CRISPR Therapeutics AG | 13,250 | — | deriv |
| 20 Jan 2026 | SALE | CRISPR Therapeutics AG | 21,433 | 51.61 USD | |
| 22 Jan 2026 | SALE | CRISPR Therapeutics AG | 60,000 | 60.23 USD | |
| 20 Jan 2026 | SALE | CRISPR Therapeutics AG | 8,567 | 52.10 USD | |
| 18 Dec 2025 | GIFT | CRISPR Therapeutics AG | 30,000 | 0.00 USD | |
| 16 Oct 2025 | EXERCISE | CRISPR Therapeutics AG | 100,000 | — | |
| 17 Oct 2025 | SALE | CRISPR Therapeutics AG | 50,895 | 67.91 USD | |
| 16 Oct 2025 | EXERCISE | CRISPR Therapeutics AG | 100,000 | — | deriv |
| 13 Oct 2025 | EXERCISE | CRISPR Therapeutics AG | 8,334 | — | |
| 14 Oct 2025 | SALE | CRISPR Therapeutics AG | 4,242 | 66.60 USD | |
| 13 Oct 2025 | EXERCISE | CRISPR Therapeutics AG | 8,334 | — | deriv |
| 03 Oct 2025 | GRANT_AWARD | CRISPR Therapeutics AG | 49,500 | 0.00 USD | deriv |